Bayer's head of digital development, Jessica Federer, says the company is transforming its business and relationships through digital initiatives – but won't lose sight of its core expertise.
A new level of collaboration is needed to overcome the current and future challenges facing healthcare globally, according to international research presented recently.
Paul Tunnah spoke to Jane Griffiths, company group chairman, Janssen pharma companies (Johnson & Johnson) EMEA, at the recent eyeforpharma Barcelona event about some of the big questions fa
